Journal articleMol Cancer Ther2019
TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer.
- Journal
- Mol Cancer Ther
- Published
- 26 December 2018
- Citations
- 117
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition F30CA236031↗
- Targeting Mixed Lineage Kinase3-Hedgehog Axis in Pancreatic Cancer I01BX002703↗
- Targeting MNK Pathways in Pancreatic Cancer I01BX002922↗
- BLR&D Research Career Scientist Award Application IK6BX004855↗
- Targeting BET Bromodomain in Pancreatic Cancer R01CA186885↗